Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZSCAN2 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-09 |
mRNA | PROX1 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
mRNA | GRIK5 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-09 |
mRNA | LDOC1L | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-09 |
mRNA | ZNF491 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-09 |
mRNA | SHISA7 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |
mRNA | BAHCC1 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-09 |
mRNA | TMSB15B | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-09 |
mRNA | C18orf32 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-09 |
mRNA | HAX1 | CTRPv2 | pan-cancer | AAC | -0.21 | 8e-09 |